AnaptysBio Inc (ANAB)
23.77
-0.48
(-1.98%)
USD |
NASDAQ |
Jun 14, 16:00
23.66
-0.11
(-0.46%)
After-Hours: 20:00
AnaptysBio 1 Year Total Returns (Daily): 28.07% for June 14, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 14, 2024 | 28.07% |
| June 13, 2024 | 27.50% |
| June 12, 2024 | 28.46% |
| June 11, 2024 | 26.47% |
| June 10, 2024 | 26.26% |
| June 07, 2024 | 25.09% |
| June 06, 2024 | 27.45% |
| June 05, 2024 | 32.48% |
| June 04, 2024 | 26.76% |
| June 03, 2024 | 25.37% |
| May 31, 2024 | 25.34% |
| May 30, 2024 | 27.49% |
| May 29, 2024 | 25.74% |
| May 28, 2024 | 25.25% |
| May 24, 2024 | 26.31% |
| May 23, 2024 | 27.80% |
| May 22, 2024 | 25.33% |
| May 21, 2024 | 25.20% |
| May 20, 2024 | 30.74% |
| May 17, 2024 | 31.60% |
| May 16, 2024 | 36.72% |
| May 15, 2024 | 32.16% |
| May 14, 2024 | 29.87% |
| May 13, 2024 | 23.34% |
| May 10, 2024 | 8.99% |
| Date | Value |
|---|---|
| May 09, 2024 | 24.73% |
| May 08, 2024 | 21.69% |
| May 07, 2024 | 17.26% |
| May 06, 2024 | 17.67% |
| May 03, 2024 | 23.63% |
| May 02, 2024 | 25.61% |
| May 01, 2024 | 22.91% |
| April 30, 2024 | 16.91% |
| April 29, 2024 | 2.31% |
| April 26, 2024 | 0.14% |
| April 25, 2024 | -12.23% |
| April 24, 2024 | -11.03% |
| April 23, 2024 | -15.06% |
| April 22, 2024 | -12.93% |
| April 19, 2024 | -13.16% |
| April 18, 2024 | -10.84% |
| April 17, 2024 | -4.87% |
| April 16, 2024 | -0.88% |
| April 15, 2024 | -1.21% |
| April 12, 2024 | 7.48% |
| April 11, 2024 | 16.54% |
| April 10, 2024 | 3.21% |
| April 09, 2024 | 0.56% |
| April 08, 2024 | -3.46% |
| April 05, 2024 | -1.08% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-87.44%
Minimum
Nov 08 2019
192.1%
Maximum
Nov 10 2020
-9.68%
Average
-11.28%
Median
May 05 2022
1 Year Total Returns (Daily) Benchmarks
| XOMA Corp | 50.16% |
| Fate Therapeutics Inc | -33.52% |
| Ocular Therapeutix Inc | 8.29% |
| Apellis Pharmaceuticals Inc | -54.41% |
| Sutro Biopharma Inc | -35.21% |